Osterweis Capital Management Inc Vericel Corp Transaction History

Osterweis Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$7.25 - $19.22 $1.25 Million - $3.31 Million	-172,220 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$13.77 - $19.2 $470,589 - $656,160	-34,175 Reduced 16.56%	172,220 $3 Million
Q3 2019 Nov 14, 2019	SELL	$14.93 - $19.83 $996,353 - $1.32 Million	-66,735 Reduced 24.43%	206,395 $3.13 Million
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $473,040 - $595,318	-31,515 Reduced 10.34%	273,130 $5.16 Million
Q1 2019 May 15, 2019	BUY	$16.23 - $20.29 $4.94 Million - $6.18 Million	304,645 New	304,645 $5.33 Million

276

48.4M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.66B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Osterweis Capital Management Inc with notifications on news.